Unternehmens-Profil
McKesson Corporation is a leading diversified healthcare services company specializing in pharmaceutical distribution and supply chain management solutions. It operates primarily through key segments including North American Pharmaceutical, which sources and distributes branded, generic, and specialty drugs to retail pharmacies, hospital networks, and healthcare providers; Oncology & Multispecialty, focusing on provider and specialty distribution growth; Prescription Technology Solutions, offering third-party logistics and technology services for pharmacies; and Medical-Surgical Solutions, supplying medical products and equipment to healthcare facilities. McKesson also engages in pharmaceutical wholesale in Canada and provides technology solutions enhancing access and efficiency in healthcare delivery. As one of three dominant players accounting for over 90% of the U.S. pharmaceutical wholesale market, alongside peers like Cencora and Cardinal Health, it partners with manufacturers, providers, pharmacies, and governments to ensure safe, timely, and cost-effective delivery of medicines and services. Founded in 1833 and headquartered in Irving, Texas, McKesson Corporation plays a critical role in the global healthcare ecosystem.
Bewertungs-Kennzahlen
Allgemeine Finanzkennzahlen
Chart · 90 Tage
Letzter Kurs: 752,51 USD· Stand 07.05.2026
News · McKesson Corporation
- MCK Stock Falls Despite Q4 Earnings Beat, Sales Miss, Margins Up
- McKesson Corporation (MCK) Q4 2026 Earnings Call Transcript
- Compared to Estimates, McKesson (MCK) Q4 Earnings: A Look at Key Metrics
- McKesson (MCK) Surpasses Q4 Earnings Estimates
- McKesson expects 2027 profit slightly above estimates on drug distribution strength